PARLIAMENTARY WRITTEN QUESTION
Hormone Replacement Therapy: Prescriptions (12 December 2023)
Question Asked
Asked by:
Ms Abena Oppong-Asare (Labour)
Answer
The figures in the table below relate to the prescribing of hormone replacement therapy (HRT) medications in England that are subsequently dispensed in the community in England, Scotland, Wales, the Isle of Man or the Channel Islands by a pharmacy, appliance contractor, dispensing doctor or have been personally administered by a general practice. They do not include data on medicines used in secondary care, prisons or issued by a private prescriber. As data is not captured on clinical indication it is not possible to distinguish between the two conditions. Data in the table for the prescribing of HRT medications is based on a list of products that are obtainable via an HRT prescription pre-payment certificate. These also exclude other medicines to treat menopause symptoms that are not licensed for that purpose that patients may be prescribed or purchase over the counter.
Year | Total Identified Patients |
2019/2020 | 1,455,591 |
2020/2021 | 1,384,489 |
2021/2022 | 1,813,228 |
2022/2023 | 2,344,680 |
2023/2024 (up to June 2023) | 1,671,792 |
Note: Data published 26 October 2023 – ‘Hormone Replacement Therapy - England - April 2015 to June 2023’, which is available at the following link: https://www.nhsbsa.nhs.uk/statistical-collections/hormone-replacement-therapy-england/hormone-replacement-therapy-england-april-2015-june-2023
Answered by:
Maria Caulfield (Conservative)
18 December 2023
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.